{"DataElement":{"publicId":"4383254","version":"1","preferredName":"PI-RADS Spectroscopy Citrate Peak And Choline Peak Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) using citrate peak and choline peak concentrations.","longName":"PIRADS_MRS_PEAKS_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4383173","version":"1","preferredName":"PI-RADS Spectroscopy Citrate Peak And Choline Peak Assessment","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating._A salt or ester of citric acid._The most extreme possible amount or value; the highest point._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Water-soluble vitamin that is a precursor for acetylcholine, phospholipids, and the methyl donor betaine. (DRI)_The most extreme possible amount or value; the highest point._The final result of a determination of the value, significance, or extent of.","longName":"4382371v1.0:4383253v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4382371","version":"1","preferredName":"Prostate Imaging-Reporting and Data System","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","longName":"C116385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93A8-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4383253","version":"1","preferredName":"Spectroscopy Citrate Peak And Choline Peak Assessment","preferredDefinition":"The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating.:A salt or ester of citric acid.:The most extreme possible amount or value; the highest point.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Water-soluble vitamin that is a precursor for acetylcholine, phospholipids, and the methyl donor betaine. (DRI):The most extreme possible amount or value; the highest point.:The final result of a determination of the value, significance, or extent of.","longName":"4383253v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spectroscopy","conceptCode":"C17155","definition":"The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Citrate","conceptCode":"C63374","definition":"A salt or ester of citric acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Peak","conceptCode":"C48054","definition":"The most extreme possible amount or value; the highest point.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Choline","conceptCode":"C61674","definition":"Water-soluble vitamin that is a precursor for acetylcholine, phospholipids, and the methyl donor betaine. (DRI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Peak","conceptCode":"C48054","definition":"The most extreme possible amount or value; the highest point.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDCAF842-741E-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"ONEDATA","dateModified":"2014-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDCA58C9-87AA-5E6D-E040-BB89AD43022B","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"7/9/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4382613","version":"1","preferredName":"PI-RADS Peak Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._The most extreme possible amount or value; the highest point._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"PIRADS_PEAK_SCORE","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"5","valueDescription":"Choline peak height exceeds citrate peak height >2 times","ValueMeaning":{"publicId":"4382614","version":"1","preferredName":"Choline peak height exceeds citrate peak height >2 times","longName":"4382614","preferredDefinition":"Choline peak height exceeds citrate peak height >2 times.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-296D-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2986-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"4","valueDescription":"Choline peak height exceeds citrate peak height >1, <2 times","ValueMeaning":{"publicId":"4382615","version":"1","preferredName":"Choline peak height exceeds citrate peak height >1, <2 times","longName":"4382615","preferredDefinition":"Choline peak height exceeds citrate peak height >1, <2 times.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2990-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-29A9-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Choline peak height equals citrate peak height","ValueMeaning":{"publicId":"4382616","version":"1","preferredName":"Choline peak height equals citrate peak height","longName":"4382616","preferredDefinition":"Choline peak height equals citrate peak height.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-29B3-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-29CC-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"2","valueDescription":"Citrate peak height exceeds Choline peak height times >1, <2 times","ValueMeaning":{"publicId":"4382617","version":"1","preferredName":"Citrate peak height exceeds Choline peak height times >1, <2 times","longName":"4382617","preferredDefinition":"Citrate peak height exceeds Choline peak height times >1, <2 times.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-29D6-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-29EF-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"1","valueDescription":"Citrate peak height exceeds Choline peak height >2 times","ValueMeaning":{"publicId":"4382618","version":"1","preferredName":"Citrate peak height exceeds Choline peak height >2 times","longName":"4382618","preferredDefinition":"Citrate peak height exceeds Choline peak height >2 times.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-29F9-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB72716-2A12-7B29-E040-BB89AD4316AD","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4382612","version":"1","preferredName":"Prostate Imaging-Reporting and Data System Peak Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.:The most extreme possible amount or value; the highest point.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C116385:C48054:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Peak","conceptCode":"C48054","definition":"The most extreme possible amount or value; the highest point.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2947-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB72716-2958-7B29-E040-BB89AD4316AD","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"7/8/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"MR spectroscopy PI-RADS score","type":"Preferred Question Text","description":"MR spectroscopy PI-RADS score using the citrate and Choline peak (3voxels)","url":null,"context":"CCR"},{"name":"Short Text","type":"Alternate Question Text","description":"MRS PI-RADS Score","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-7435-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}